Detalles de la búsqueda
1.
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
N Engl J Med
; 388(19): 1767-1778, 2023 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163623
2.
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 377(4): 352-360, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578607
3.
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 20(5): 686-700, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30987939
4.
Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC).
Support Care Cancer
; 23(11): 3281-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25940030
5.
Attitudes and beliefs of Argentinian medical oncologists regarding palliative care referral.
Medicina (B Aires)
; 83(1): 10-18, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774592
6.
Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer.
J Clin Oncol
; 41(1): 65-74, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858154
7.
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Clin Drug Investig
; 43(9): 699-706, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594640
8.
Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.
Cancer
; 118(5): 1252-9, 2012 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21898376
9.
Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study.
JCO Glob Oncol
; 8: e2100276, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324270
10.
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
Breast Cancer Res Treat
; 122(2): 409-18, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20454927
11.
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study.
Eur Urol
; 77(4): 494-500, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31843335
12.
Attitudes and beliefs of argentinian medical oncologists regarding palliative care referral / Actitudes y creencias de los médicos oncólogos argentinos sobre la derivación a cuidados paliativos
Medicina (B.Aires)
; 83(1): 10-18, abr. 2023. graf
Artículo
en Inglés
|
LILACS-Express
| ID: biblio-1430767
13.
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Clin Drug Investig
; 43(9): 707-708, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695417
14.
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer.
Lung Cancer
; 58(1): 80-7, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17588704
15.
A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).
Clin Breast Cancer
; 16(1): 38-44, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26642810
16.
Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies.
Breast
; 21(1): 89-94, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21937232
17.
Demoras en el proceso de atención de pacientes con cáncer de mama en dos hospitales públicos de la provincia de Santa Fe / Delays in the process of care of patients with breast cancer in two public hospitals in the province of Santa Fe
Rev. argent. salud publica
; 7(27): 21-26, jun. 2016. tab
Artículo
en Español
| LILACS | ID: biblio-869567
18.
Cetuximab Plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan: the LABEL study.
Clin Colorectal Cancer
; 9(5): 282-9, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21208842
19.
Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer.
Eur J Cancer
; 45(17): 2940-6, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19683429
20.
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
J Clin Oncol
; 26(10): 1664-70, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18316794